RxDoctor Payments Data

Daniel Witmer, MD

Orthopaedic Surgery · Farmington, CTNPI 1396005419

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,373 of the $4,938 with a category attached, or 68.3%. Zimmer Biomet accounts for 67.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,883 and has fallen 54.7% since, to $854 in 2025.

$4,938in general payments, 2019–2025

Across 46 payments — averaging $107.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$3K
  • Stryker$947
  • Johnson & Johnson$174
  • Osteoremedies, LLC$159
  • Intellijoint Surgical Inc.$154
  • Amniox Medical, Inc.$103
  • plus $50 from 2 others
$1,654in research payments, 2019–2025

Across 1 payment — averaging $1653.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$2K

What the payments were for

  • Travel & lodging$1,47630%
  • Food & beverage$3,37368%
  • Education$892%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,938 in reported general payments places this provider in the 60th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024
$334,763
Medicare patients
614
Services billed
2,610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium36$717
Meloxicam149$703
Methocarbamol90$692
ErythromycinErythromycin Base12$628
Cephalexin14$514
Oxycodone Hcl60$491
Amoxicillin245$458
Minocycline Hcl11$325
Cefadroxil22$297
Gabapentin43$291
Tramadol Hcl48$174
Clindamycin Hcl42$136
Methylprednisolone19$86
Hydromorphone Hcl12$85
Cyclobenzaprine Hcl11$72

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Farmington

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →